Galleri by GRAIL vs Tempus
Side-by-side comparison of cancer screening tests.
← Back to Cancer Screening
Test Performance
| Feature | Galleri by GRAIL | Tempus |
|---|---|---|
| Price | $949 | Variable |
| Cancers Detected | 50+ cancers | 648 genes |
| Sensitivity | >70% for the 12 deadliest cancers | N/A |
| Specificity | 99.6% (0.4% false positive rate) | N/A |
| Sample Type | Blood draw | Tumor tissue + blood |
| FDA Status | Not FDA approved (PMA under review;advisory panel Sept 2026) | FDA approved (CDx) |